Tenax Therapeutics, Inc.
TENXNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $76.81M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.31$19.40
- Volume (live)
- -
- Avg. volume (3M)
- 3.50M
Tenax Therapeutics (TENX) Stock Price & Financial Analysis
Tenax Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.51 - $1.56 |
|---|---|
| 52-Week High | $19.40 |
| 52-Week Low | $1.31 |
| Open | $1.55 |
| Volume (last close) | 2.01M |
| Average Volume (3M) | 3.50M |
| 50-Day MA | $2.55 |
|---|---|
| 200-Day MA | $10.77 |
| 1-Year Change | −77.86% |
| Market Cap | 76.81M |
|---|---|
| Shares Outstanding | 50.87M |
| Price to Book (P/B) | 0.68 |
| EV/EBITDA | 0.63 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Tenax Therapeutics at a Glance
As of the Oct 15, 2026 close, Tenax Therapeutics (TENX) has a market capitalization of $76.81M.
As of its latest reported balance sheet, it holds $117.98M in cash and securities against $0.00 of debt, a net cash position of $117.98M.
Tenax Therapeutics does not currently pay a dividend.
The share price is down 77.9% over the past year. At $1.51 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $1.31 to $19.40, below its 200-day moving average of $10.77.
Based on 11 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $9.63, 537.7% above the Oct 15, 2026 close.
Frequently Asked Questions About Tenax Therapeutics
What is the current stock price for TENX?
As of the Oct 15, 2026 close, TENX stock trades at $1.51. The 52-week range is $1.31–$19.40, with a day range of $1.51–$1.56.
What is the P/E ratio for TENX?
The P/E ratio (Price-to-Earnings) for TENX is shown in the Key Statistics section. This valuation metric helps compare Tenax Therapeutics, Inc. to industry peers.
Does TENX pay dividends?
Tenax Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TENX?
Based on ratings from 11 professional analysts over the last 90 days, the consensus for TENX is Buy. The average 12-month price target is $9.63, a 537.7% upside from the Oct 15, 2026 close of $1.51.
What is the market cap of TENX?
As of the Oct 15, 2026 close, Tenax Therapeutics's market capitalization is $76.8M, classifying it as a micro-cap company. Tenax Therapeutics operates in the Healthcare sector within the Biotechnology industry.